Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.17472 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Eduardo Rivera-Mancilla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: TRPM Cation Channels, Sex Characteristics, Coronary Vessels, Transient Receptor Potential Channels. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, Secretaría de Educación, Ciencia, Tecnología e Innovación del Gobierno de la Ciudad de México, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Background and Purpose Sex‐dependent vascular effects of transient receptor potential (TRP) channels and sex dimorphism in migraine are not yet fully characterized. We investigated the differential vasoactive effects of TRP ankyrin 1 (TRPA1), TRP melastatin 3 (TRPM3) and TRP vanilloid 1 (TRPV1) channels, their pharmacological mechanism(s), and localization and expression in human isolated blood vessels. Experimental Approach Agonist responses to cinnamaldehyde (TRPA1), pregnenolone sulfate (PregS, TRPM3) or capsaicin (TRPV1) were analysed using wire myography in segments of human coronary (HCAs) and middle meningeal (HMMAs) arteries from men and women. The mechanisms involved in these responses were investigated using the antagonists/blockers/inhibitors: HC‐030031 (TRPA1), isosakuranetin (TRPM3), capsazepine (TRPV1), olcegepant (calcitonin gene‐related peptide [CGRP] receptor), L‐NAME (nitric oxide synthase [NOS]), indomethacin (cyclooxygenase [COX]), TRAM‐34 + apamin (K + channels) or MK‐801 ( N ‐methyl‐ d ‐aspartate [NMDA] receptor). Fluorescence microscopy, quantitative polymerase chain reaction (qPCR), and western blotting were performed to investigate their location and expression, respectively. Key Results In HCAs and HMMAs, (i) capsaicin‐induced relaxation remained unchanged after the above‐mentioned antagonists/blockers/inhibitors and (ii) cinnamaldehyde‐induced relaxation was blocked by olcegepant. PregS‐induced maximal relaxation was significantly enhanced in isolated arteries from females compared with males and was inhibited after isosakuranetin, MK‐801 or L‐NAME. TRPM3 mRNA and protein expression, along with NMDA protein levels, were higher in arteries from females than males. Conclusion and Implications Modulation of vascular tone in HCAs and HMMAs by activation of TRPM3 is sex‐dependent, likely involving NMDA receptors. This represents a new therapeutic direction, targeting sex dimorphism in migraine and its related cardiovascular events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Heart Valve Department, ETB-BISLIFE, Beverwijk, The Netherlands.
- Department of Neurosurgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Department of Pharmacobiology, Cinvestav-Coapa, Mexico City, Mexico.
ORCID-Profile: Eduardo Rivera-Mancilla, Carlos M Villalón, Alexander H J Danser, Antoinette MaassenVanDenBrink
Förderung
- Consejo Nacional de Ciencia y Tecnología
- Secretaría de Educación, Ciencia, Tecnología e Innovación del Gobierno de la Ciudad de México
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Rivera-Mancilla, E., Musterd-Bhaggoe, U. M., Schutter, D., van den Bogaerdt, A., Vincent, A. J. P. E., Villalón, C. M., Danser, A. H. J., & MaassenVanDenBrink, A. (2025). Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders. British Journal of Pharmacology. https://doi.org/10.1111/bph.17472
Vancouver
Rivera-Mancilla E, Musterd-Bhaggoe UM, Schutter D, van den Bogaerdt A, Vincent AJPE, Villalón CM, et al. Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders. British Journal of Pharmacology. 2025. doi:10.1111/bph.17472
BibTeX
@article{RiveraMancilla2025,
author = {Rivera-Mancilla, Eduardo and Musterd-Bhaggoe, Usha M and Schutter, Dennis and van den Bogaerdt, Antoon and Vincent, Arnaud J P E and Villalón, Carlos M and Danser, Alexander H J and MaassenVanDenBrink, Antoinette},
title = {Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.17472}
}
EUVIMED